MedPath

Pupillometry in Delayed Sleep Wake Phase Disorder

Not Applicable
Not yet recruiting
Conditions
Delayed Sleep-Wake Phase Disorder
Registration Number
NCT06949644
Lead Sponsor
Northwestern University
Brief Summary

The goal of this observational study is to characterize the pupil light response in patients with delayed sleep-wake phase disorder. A subset of participants will take part in a clinical trial to determine if increasing serotonin can alter the circadian response to light. The main questions it aims to answer is:

Are there differences in the light response in patients with delayed sleep-wake phase disorder? Does citalopram increase melatonin suppression in patients with delayed sleep-wake phase disorder?

Participants will complete activity and melatonin testing at home to determine their circadian timing. This will be followed by an eye test looking at the pupil response to different light stimuli. A subset of participants will complete two inpatient admissions where melatonin levels will be sampled and they will be exposed to a bright light. During one round of testing they will receive a placebo and in the other round of testing they will take a single dose of citalopram, a selective serotonin reuptake inhibitor.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
220
Inclusion Criteria
  • Delayed sleep-wake phase disorder
Exclusion Criteria
  • Use of medications known to alter pupil diameter
  • History of eye disease or eye surgery
  • Unstable medical or psychiatric condition
  • Shift work or self imposed irregular sleep schedules
  • Caffeine consumption >400mg/day

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Melatonin suppression8 hours

Saliva melatonin samples will be collected before and after light exposure

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath